Clinical research for the validation of a non invasive medical imaging device fo...
Clinical research for the validation of a non invasive medical imaging device for dermatological diagnoses
Diagnosis and study of many diseases in dermatology, including cancers, mainly depend on biopsy and histopathological analysis of tissue at the cellular-level using an optical microscope. This medical procedure implies to perform...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SkinOptima
Link Skin Morphology and Vasculature with Diseases using Opt...
270K€
Cerrado
DERMAGNOSTIX
Pioneering diagnostics in dermatology and cancer
5M€
Cerrado
PCIN-2015-241
ADVANCING SMART OPTICAL IMAGING AND SENSING FOR HEALTH
128K€
Cerrado
SKIN-CANCER-PROBE
A novel handheld probe coupled to mass spectrometer as a non...
145K€
Cerrado
RETINAL
Retinal imaging prevention and early detection of chronic di...
2M€
Cerrado
Información proyecto DERMAE
Duración del proyecto: 3 meses
Fecha Inicio: 2015-06-16
Fecha Fin: 2015-09-30
Líder del proyecto
DAMAE MEDICAL
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Diagnosis and study of many diseases in dermatology, including cancers, mainly depend on biopsy and histopathological analysis of tissue at the cellular-level using an optical microscope. This medical procedure implies to perform a biopsy, i.e. to excise a portion of tissue, then to freeze and cut the sample into slices of a few micrometers thickness and use specific dyes. This procedure is painful and potentially dangerous for the patient. Moreover it is time-consuming and may introduce structural deformation or damages.
Skin diseases like Melanoma are rapidly growing throughout the world. About 12 millions biopsies are performed each year by dermatologists. As a minor surgical act, the biopsy process involves pain, possible scarring, and stress during the 15 days before reception of analyses results. In 60% of the cases, the skin anomaly is benign and do not necessitate further treatment. However, the patients need to consult another time with the dermatologist for the announcement of the results of the biopsy, which incurs extra medical costs and time. Moreover, as symptoms are detected on a macroscopic-level with surface criteria (color, form and size of the lesion), the dermatologist misses over one third of the pathologies. Finally, as the tissue excision is visually performed, 40% of reoperation is necessary to remove the entire tumor.
DERMAE is a highly recognized and awarded innovative project that solves this major healthcare issue by developing an innovative instrument capable of producing in situ images of biological tissues similar to histological sections. This non- invasive imaging technique will be able to image in real time the internal structures (up to 1 mm deep) of biological tissues at the cellular level (about 1 μm resolution). This imaging technology will constitute a new diagnostic tool that may revolutionize the medical procedures in dermatological diagnoses.